Nighttime blood pressure reductions after radiofrequency renal denervation through 24 months in patients with uncontrolled hypertension: pooled analysis from the SPYRAL HTN trials

30 August 2024 (09:09 - 09:27)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Konstantinos Tsioufis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on device-based hypertension management

Professor I. Sudano (Zurich, CH)

Presentation thumbnail

Blood pressure and renal function changes in patients with severe chronic kidney disease undergoing radiofrequency renal denervation: 12 months outcomes from the Global SYMPLICITY Registry DEFINE

Professor M. Schlaich (Perth, AU)

Abstract Slides Video

Presentation thumbnail

Efficacy comparison of transcatheter aorticorenal ganglion ablation and renal denervation in a hypertensive canine model

Doctor Y. Long (Chongqing, CN)

Abstract Slides Video

Presentation thumbnail

The relationship between lung MIBG uptake and clinical response to renal denervation

Doctor H. Dalpiaz (Pisa, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Device-based hypertension therapies: third pillar in hypertension management?

The Event

Event poster

ESC Congress 2024

30 August 2024 09:09 CET

You may be interested in

Congress Presentation

The evidence that matters: the SPYRAL HTN clinical journey

Congress Presentation

Renal denervation is one of the pillars of management of resistant hypertension: pro

Congress Presentation

Renal denervation lowers all-cause and cardiovascular mortality in patients with uncontrolled arterial hypertension: a randomised, sham-controlled study.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources